Occurrence and Distribution of 17 Targeted Human Pharmaceuticals in Various Aquatic Environmental Matrices in Southeast Asia with Particular Reference to Malaysia: A Comprehensive Review

Autor: Norbaya Hashim, Ali Yuzir, Fouad Fadhil Al-Qaim, Nasehir Khan E.M. Yahaya

Publikováno v: Journal of the Mexican Chemical Society. 65

This review focuses on the occurrence and distribution of 17 targeted human pharmaceutical compounds from the most common therapeutic classes. These include one analgesic (acetaminophen), three non-steroidal anti-inflammatory drugs (NSAIDs) (acetylsa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9c9bbc2927eb8513cf73b1783887146f
https://doi.org/10.29356/jmcs.v65i3.1487

Solicitud cetirizina tableta y jarabe

Autor: Perú. Ministerio de salud, Dirección General de Medicamentos, Insumos y Drogas

Publikováno v: Dirección General de Medicamentos, Insumos y Drogas
Repositorio institucional DIGEMID
DIGEMID-Institucional
Dirección General de Medicamentos, Insumos y Drogas (Digemid) – Ministerio de Salud
instacron:DIGEMID

En la revisión de las solicitudes presentadas respecto al medicamento cetirizina 5mg/mL jarabe y 10mg tableta, se observa que el expediente señala que existe un vacío terapéutico, y debido a que en el Petitorio Nacional Único de Medicamentos Ese

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::3ab7b1f450c89e1cf88d5d709f950115
http://repositorio.digemid.minsa.gob.pe/handle/DIGEMID/73

Rinitis alérgica : Tratamiento con montelukast sólo o en combinación con antihistamínicos orales. Revisión sistemática

Autor: Castellanos Mateus, Sandra Marcela, Ortiz Lozano, Karla Jimena, Jimenez Villa, Luis Guillermo

Publikováno v: Baena Cagnani CE, Solé D, González Díaz SN, Zernotti ME, Sisul JC, Sánchez Borges M, et al. Actualización de rinitis alérgica y su impacto en el asma (ARIA 2008). La perspectiva latinoamericana. Rev Alerg México. 56(2):56-63.
Ruby Pawankar SM, Chika Ozu SK. Overview on the pathomechanisms of allergic rhinitis. Asia Pac Assoc Allergy Asthma Clin Immunol. 2011;1:157-67.
Jean Bousquet. Allergic Rhinitis and its Impact on Asthma. J Allergy Clin Immunol. 2001;108:147-336.
Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011;378(December 17/24/31):2112-22.
Van Hoecke H, Vandenbulcke L, Van Cauwenberge P. Histamine and Leukotriene Receptor Antagonism in the Treatment of Allergic Rhinitis An Update. Drugs. 2007;67(18):2717-26.
Wheatley LM, Togias A. Allergic Rhinitis. N Engl J Med. 372(5):456-63.
Ibiapina C da C, Sarinho ESC, Camargos PAM, Andrade CR de4, Cruz Filho ÁAS da. Allergic Rhinitis: epidemiological aspects, diagnosis and treatment. J Bras Pneumol. 2008;34(4):230-40.
Arévalo Herrera M, Reyes MA, Victoria L, Villegas A, Badiel M, Herrera S. Asma y rinitis alérgica en pre-escolares en Cali. 15 de enero de 2014 [citado 12 de junio de 2016]; Disponible en: http://bibliotecadigital.univalle.edu.co/handle/10893/6822
Alfredo Mendoza Amatller GMC. Rinitis alérgica. Rev Soc Boliv Pediatría. 2002;41(1):50-3.
Sanjay N. Mandhane, Jigar H. Shah, Rajammanar Thennati. Allergyc rhinitis: an update on desease, present treatments and future pospects. Int Immunopharmacol. 2011;11:1646-62.
Togias A. Current reviews of allergy and clinical immunology rhynitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol. 2003;111:1171-83.
Berger WE. Pediatric Allergic Rhinitis: Antihistamine Selection. Clin Piediatric. 2005;44:655-64.
Jadad AR. Asessing the quality of reports of randpmizad clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
Ciebiada M, Barylski M, Ciebiada MG. Nasal eosinophilia and serum soluble intercellular adhesion molecule-1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine. Am J Rhinol Allergy. 2013;27(2):e58-62.
Horak F, Zieglmayer P, Zieglmayer R, Lemell P. Onset of action of loratadine/montelukast in seasonal allergic rhinitis patients exposed to grass pollen. Arzneimittelforschung. 2010;60(2):249.
Prenner B, Anolik R, Danzig M, Yao R. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion. Allergy Asthma Proc Off J Reg State Allergy Soc. junio de 2009;30(3):263-9.
Day JH, Briscoe MP, Ratz JD, Danzig M, Yao R. Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. abril de 2009;102(4):328-38.
Ciebiada M, Górska-Ciebiada M, DuBuske LM, Górski P. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. noviembre de 2006;97(5):664-71.
Kurowski M, Kuna P, Górski P. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation. Allergy. marzo de 2004;59(3):280-8.
Nayak AS, Philip G, Lu S, Malice M-P, Reiss TF, Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. junio de 2002;88(6):592-600.
Wilson AM, Orr LC, Coutie WJR, Sims EJ, Lipworth BJ. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis. Clin Exp Allergy J Br Soc Allergy Clin Immunol. enero de 2002;32(1):126-32.
Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. mayo de 2000;105(5):917-22.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario

Antecedentes: La rinitis alérgica es una enfermedad secundaria a la exposición a alérgenos con una inflamación de las mucosas nasales mediadas por la Ig-E, tiene síntomas como estornudos, obstrucción nasal, prurito nasal y descarga nasal. Los t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::779375e4dc8bb51e9731c07a0cf77e46
http://repository.urosario.edu.co/handle/10336/12468

Rythmes circadiens des effets toxiques d'un antihistaminique H1 : la cétirizine chez la souris

Autor: M. Ben Attia, Naceur A. Boughattas, Dorra Dridi, Alain Reinberg

Publikováno v: Pathologie Biologie. 53:193-198

Resume La cetirizine est un antihistaminique H1 de seconde generation, largement utilise en clinique pour ses proprietes antiallergiques. But de l'etude. – Voir, si la survie et la toxicite neurocomportementale (ataxie) dependent du temps d'adminis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6a251b86122fee6e972b94bdcd3234c4
https://doi.org/10.1016/j.patbio.2004.07.014

Distributions of results of cetirizine dihydrochloride assay in bulk material

Autor: Alexander Weisman, I. Kuselman

Publikováno v: International Journal of Pharmaceutics. 221:159-163

The distribution of the cetirizine dihydrochloride assay results in correlation with the pharmacopoeia limits is analyzed. The data for analysis were obtained at Chemagis Ltd., Israel, for 13 batches during a year in two laboratories by five analysts

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e52fcb805d86e2fe31cb65e9259247f
https://doi.org/10.1016/s0378-5173(01)00680-9